Free Trial

Kindly MD (KDLY) Competitors

Kindly MD logo
$0.97
-0.04 (-3.96%)
(As of 11/1/2024 ET)

KDLY vs. TOI, RNLX, OPGN, PMD, MRAI, BRTX, CMAX, OTRK, BGLC, and ATPC

Should you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Oncology Institute (TOI), Renalytix (RNLX), OpGen (OPGN), Psychemedics (PMD), Marpai (MRAI), BioRestorative Therapies (BRTX), CareMax (CMAX), Ontrak (OTRK), BioNexus Gene Lab (BGLC), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry.

Kindly MD vs.

Oncology Institute (NASDAQ:TOI) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, community ranking, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Oncology Institute received 4 more outperform votes than Kindly MD when rated by MarketBeat users.

CompanyUnderperformOutperform
Oncology InstituteOutperform Votes
4
66.67%
Underperform Votes
2
33.33%
Kindly MDN/AN/A

36.9% of Oncology Institute shares are held by institutional investors. 9.5% of Oncology Institute shares are held by insiders. Comparatively, 50.5% of Kindly MD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Kindly MD has a net margin of 0.00% compared to Oncology Institute's net margin of -18.86%. Kindly MD's return on equity of 0.00% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
Oncology Institute-18.86% -136.63% -33.56%
Kindly MD N/A N/A N/A

Oncology Institute currently has a consensus target price of $2.50, suggesting a potential upside of 733.61%. Given Oncology Institute's higher probable upside, equities research analysts plainly believe Oncology Institute is more favorable than Kindly MD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oncology Institute
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Kindly MD
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Oncology Institute and Oncology Institute both had 4 articles in the media. Kindly MD's average media sentiment score of 0.28 beat Oncology Institute's score of -0.49 indicating that Kindly MD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oncology Institute
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Kindly MD
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kindly MD has lower revenue, but higher earnings than Oncology Institute.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oncology Institute$324.24M0.07-$83.07M-$0.79-0.38
Kindly MDN/AN/AN/AN/AN/A

Summary

Oncology Institute and Kindly MD tied by winning 5 of the 10 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KDLY vs. The Competition

MetricKindly MDHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$5.77M$890.51M$5.41B$8.53B
Dividend YieldN/A2.20%5.15%4.14%
P/E RatioN/A31.61113.5915.14
Price / SalesN/A4.071,480.9593.55
Price / CashN/A23.3739.8334.04
Price / BookN/A3.044.645.02
Net IncomeN/A-$10.72M$119.13M$225.46M
7 Day Performance-4.91%7.17%0.78%0.37%
1 Month Performance-6.59%13.71%5.66%3.57%
1 Year PerformanceN/A335.66%36.85%29.42%

Kindly MD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KDLY
Kindly MD
N/A$0.97
-4.0%
N/AN/A$5.77MN/A0.00N/ANews Coverage
TOI
Oncology Institute
2.3103 of 5 stars
$0.30
-3.3%
$2.50
+733.6%
-85.7%$22.64M$324.24M-0.38660Gap Down
RNLX
Renalytix
1.2377 of 5 stars
$0.21
+5.7%
$3.00
+1,348.6%
-79.7%$17.18M$2.29M-0.53100Gap Up
OPGN
OpGen
N/A$1.75
+4.8%
N/A-72.0%$14.63M$3.42M0.00100Analyst Forecast
News Coverage
Gap Up
PMD
Psychemedics
N/A$2.33
flat
N/A-6.5%$13.73M$20.79M-2.99140Positive News
High Trading Volume
MRAI
Marpai
N/A$0.88
-6.8%
$6.00
+584.9%
+76.9%$12.04M$37.15M-0.26150
BRTX
BioRestorative Therapies
4.0457 of 5 stars
$1.55
-0.6%
$18.00
+1,061.3%
-12.2%$10.73M$150,000.00-0.767Short Interest ↓
Positive News
CMAX
CareMax
3.4828 of 5 stars
$2.15
-0.9%
$45.00
+1,993.0%
-96.2%$8.21M$751.10M-0.011,450News Coverage
Gap Up
High Trading Volume
OTRK
Ontrak
1.9959 of 5 stars
$1.83
+1.1%
$45.00
+2,359.0%
-88.7%$7.72M$12.74M-0.05250Gap Up
BGLC
BioNexus Gene Lab
0.9921 of 5 stars
$0.37
+2.8%
N/A+3.9%$6.65M$9.77M0.0030Positive News
ATPC
Agape ATP
N/A$1.69
-0.6%
N/A-90.4%$6.51M$1.43M-2.8240Gap Up

Related Companies and Tools


This page (NASDAQ:KDLY) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners